Since triple negative breast cancer is known to have a poor prognosis [53], ER (Estrogen Receptor), PR (Progesterone Receptor), and HER-2 (Human Epidermal growth factor Receptor 2) are highly relevant markers. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.